# A Phase 2 Study of HW211026

> clinical trial · VERIFIED · 2026-07-09

Status: NOT_YET_RECRUITING · Sponsor: Hubei Bio-Pharmaceutical Industrial Technological Institute Inc. · Condition: Actinic Keratosis

- Company: Hubei Bio-Pharmaceutical Industrial Technological Institute Inc.
- Sector: Actinic Keratosis
- Primary source: https://clinicaltrials.gov/study/NCT07513454

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.